Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2012
05/10/2012US20120115161 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
05/10/2012US20120114766 Substituted chroman derivatives, medicaments and use in therapy
05/10/2012US20120114765 Anti-neoplastic compounds, compositions and methods
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114756 Sustained-release drug carrier composition
05/10/2012US20120114750 Pharmaceutical composition 271
05/10/2012US20120114749 Compositions and methods for delivery of embolics
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114704 Compounds, compositions and methods of treating cancer and fibrotic diseases
05/10/2012US20120114701 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
05/10/2012US20120114692 Immunogenic compositions containing phospholipid
05/10/2012US20120114685 Compositions comprising angiogenic factors and methods of use thereof
05/10/2012US20120114681 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
05/10/2012US20120114680 Dendritic Cell Compositions and Methods
05/10/2012US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/10/2012US20120114676 Methods of treating cancer with phenformin
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114673 Compositions and methods for the diagnosis and treatment of tumor
05/10/2012US20120114672 Antibodies Specific to Cadherin-17
05/10/2012US20120114671 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation
05/10/2012US20120114670 Methods and compositions related to synergistic responses to oncogenic mutations
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114665 Human antibodies to human rankl
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114658 Treatment of cancer
05/10/2012US20120114651 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
05/10/2012US20120114649 Compositions of pd-1 antagonists and methods of use
05/10/2012US20120114648 Compositions of pd-1 antagonists and methods of use
05/10/2012US20120114644 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
05/10/2012US20120114643 4-pyridinone compounds and their use for cancer
05/10/2012US20120114641 Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
05/10/2012US20120114640 MODULATION OF THE TGF- ß AND PI3K/AKT PATHWAYS IN THE DIAGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMA
05/10/2012US20120114638 Combination therapy
05/10/2012US20120114636 Low molecular weight cyclin e (lmw-e) as a biomarker for personalization of cancer therapies
05/10/2012US20120114634 Methods for inducing a sustained immune response against a b-cell idiotype using autologous anti-idiotypic vaccines
05/10/2012US20120114620 Engineered Dendritic Cells and Uses for the Treatment of Cancer
05/10/2012US20120114612 Oncolytic Viruses And Methods For Treating Neoplastic Disorders
05/10/2012US20120114607 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
05/10/2012US20120114605 Methods and compositions relating to hematologic malignancies
05/10/2012US20120114602 Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof
05/10/2012US20120114599 Opioid and opioid-like compounds and uses thereof
05/10/2012US20120114597 Cd4+cd25- t cells and tr1-like regulatory t cells
05/10/2012US20120114593 Method and composition for altering a b cell mediated pathology
05/10/2012US20120114577 Peptide Having Activity of Transforming Growth Factor and Production Method Therefor
05/10/2012US20120114565 Compounds modulators of vegf activity and uses thereof
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012DE102010050558A1 1H-Pyrrolo[2,3-b]pyridinderivate 1H-pyrrolo [2,3-b] pyridine
05/10/2012DE102010048800A1 Chinoxalinderivate Quinoxaline derivatives
05/10/2012CA2854437A1 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012CA2829117A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/10/2012CA2816963A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid
05/10/2012CA2816957A1 Compositions and methods for treating myelofibrosis
05/10/2012CA2816929A1 Synthetic lethality in cancer
05/10/2012CA2816919A1 C-met antibody combinations
05/10/2012CA2816896A1 1h-pyrrolo[2,3-b]pyridine derivatives
05/10/2012CA2816855A1 Combination therapy for prostate cancer using botanical compositions and bicalutamide
05/10/2012CA2816839A1 Peg or peg block copolymers for treating colorectal cancer
05/10/2012CA2816797A1 Microsphere comprising a lanthanide metal complex
05/10/2012CA2816745A1 Anti c-met antibodies
05/10/2012CA2816681A1 Cytotoxic agents comprising new ansamitocin derivatives
05/10/2012CA2816584A1 Compositions of a peptide-based system for cell-specific targeting
05/10/2012CA2816519A1 Pan-her antibody composition
05/10/2012CA2816322A1 Isoflavonoid compositions and methods for the treatment of cancer
05/10/2012CA2816319A1 Isoflavonoid compounds and methods for the treatment of cancer
05/10/2012CA2816219A1 Benzamides and nicotinamides as syk modulators
05/10/2012CA2816121A1 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
05/10/2012CA2815611A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012CA2815445A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k-delta inhibitors
05/10/2012CA2815266A1 Stable heterodimeric antibody design with mutations in the fc domain
05/09/2012EP2450352A1 Prophylactic or therapeutic agent for cancer
05/09/2012EP2450057A1 Novel forms of CDDO methyl ester
05/09/2012EP2450055A1 Method for suppressing tumor growth by blocking fibroblast growth factor receptor, and method for diagnosing malignant neoplasms
05/09/2012EP2450037A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers
05/09/2012EP2449114A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors
05/09/2012EP2448952A2 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof
05/09/2012EP2448946A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors
05/09/2012EP2448942A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS
05/09/2012EP2448941A2 Pyrazolopyrimidine jak inhibitor compounds and methods
05/09/2012EP2448940A2 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
05/09/2012EP2448937A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/09/2012EP2448935A1 Substituted 2-carboxamide cycloamino ureas
05/09/2012EP2448932A1 Novel 6-morpholin-4-yl-pyrimidin-4-(3h)-one derivatives, and the pharmaceutical preparation thereof as akt(pkb) phosphorylation inhibitors
05/09/2012EP2448931A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448929A1 Novel conjugates, preparation thereof, and therapeutic use thereof
05/09/2012EP2448927A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
05/09/2012EP2448924A2 Pyrazole derivatives, preparation thereof, and therapeutic use thereof
05/09/2012EP2448923A1 Smac mimetic
05/09/2012EP2448922A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones
05/09/2012EP2448920A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448594A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor
05/09/2012EP2448588A1 Methods and compositions for treating cancer
05/09/2012EP2448582A1 Therapeutic compounds and compositions
05/09/2012EP2448581A1 Therapeutic compositions and related methods of use
05/09/2012EP2324008B1 3,4-diarylpyrazoles as protein kinase inhibitors
05/09/2012EP2318413B1 Pyrrolobenzodiazepines
05/09/2012EP2293807B1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia
1 ... 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 ... 2211